A clinically applicable integrative molecular classification of meningiomas

Farshad Nassiri, Jeff Liu, Vikas Patil, +23

Nature

Neuro-oncologyEngineeringMedicineHistopathologyPathology +4

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

Farshad Nassiri, Vikas Patil, Leeor Yefet, +36

Nature Medicine

Cortical-Bone Fragility — Insights from sFRP4 Deficiency in Pyle’s Disease

Pelin Özlem Şimşek‐Kiper, Hiroaki Saito, Francesca Gori, +21

New England Journal of Medicine

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes

Christopher G. Duncan, Patrick Killela, Cathy A. Payne, +11

Oncotarget

Ascorbate Synthesis Pathway

Kenneth H. Gabbay, Kurt M. Bohren, Roy Morello, +3

Journal of Biological Chemistry

Ascorbate Synthesis PathwayOsteoporosisOxidative StressBiosynthesisBone Morphogenic Protein +14

High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes

Robert Brommage, Jeff Liu, Gwenn M. Hansen, +6

Bone Research

GeneticsGene CharacterizationDisease Gene IdentificationGene Expression ProfilingOsteoporosis +20

PTH Stimulates Bone Formation in Mice Deficient in Lrp5

Urszula T. Iwaniec, Thomas J. Wronski, Jeff Liu, +4

Journal of Bone and Mineral Research

NOTUM inhibition increases endocortical bone formation and bone strength

Robert Brommage, Jeff Liu, Peter Vogel, +20

Bone Research

Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells

Sameer Agnihotri, Sheila Mansouri, Kelly Burrell, +15

Clinical Cancer Research

Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis

Weirong Xing, Jeff Liu, Shaohong Cheng, +3

Journal of Bone and Mineral Research